
Anoop Kumar Singh
Examiner (ID: 8256, Phone: (571)272-3306 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 967 |
| Issued Applications | 309 |
| Pending Applications | 158 |
| Abandoned Applications | 545 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12138465
[patent_doc_number] => 20180016548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'ACELLULAR SCAFFOLDS FOR MATURATION OF IPSC-HEPATOCYTES'
[patent_app_type] => utility
[patent_app_number] => 15/650481
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13650
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650481
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650481 | ACELLULAR SCAFFOLDS FOR MATURATION OF IPSC-HEPATOCYTES | Jul 13, 2017 | Abandoned |
Array
(
[id] => 12137101
[patent_doc_number] => 20180015183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS'
[patent_app_type] => utility
[patent_app_number] => 15/643430
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15408
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643430
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643430 | METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS | Jul 5, 2017 | Abandoned |
Array
(
[id] => 18543650
[patent_doc_number] => 11716974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Human liver chimeric mouse with deficient P450 oxidoreductase
[patent_app_type] => utility
[patent_app_number] => 16/309871
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 50
[patent_no_of_words] => 16835
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309871 | Human liver chimeric mouse with deficient P450 oxidoreductase | Jun 26, 2017 | Issued |
Array
(
[id] => 15033881
[patent_doc_number] => 20190327945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => REGENERATION METHOD USING SOMATIC CELL NUCLEAR TRANSFER (SCNT) CELL AND BLASTOCYST COMPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 16/309907
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309907
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309907 | REGENERATION METHOD USING SOMATIC CELL NUCLEAR TRANSFER (SCNT) CELL AND BLASTOCYST COMPLEMENTATION | Jun 13, 2017 | Pending |
Array
(
[id] => 11971457
[patent_doc_number] => 20170275611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'METHODS, CELLS & ORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 15/610384
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32318
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15610384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/610384 | METHODS, CELLS & ORGANISMS | May 30, 2017 | Abandoned |
Array
(
[id] => 19651534
[patent_doc_number] => 12173305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => cis and trans requirements for terminal resolution of human bocavirus 1
[patent_app_type] => utility
[patent_app_number] => 16/304064
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 43
[patent_no_of_words] => 23001
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304064 | cis and trans requirements for terminal resolution of human bocavirus 1 | May 25, 2017 | Issued |
Array
(
[id] => 13563915
[patent_doc_number] => 20180333505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => SELECTIVE INSERTION OF SUICIDE GENES INTO CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 15/601102
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601102
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601102 | SELECTIVE INSERTION OF SUICIDE GENES INTO CANCER CELLS | May 21, 2017 | Abandoned |
Array
(
[id] => 14744037
[patent_doc_number] => 20190255192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/300446
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300446 | Adeno-associated virus variant capsids and methods of use thereof | May 11, 2017 | Issued |
Array
(
[id] => 18964411
[patent_doc_number] => 11898163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Method for producing dopaminergic neuron progenitor cell
[patent_app_type] => utility
[patent_app_number] => 16/095092
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 15560
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095092 | Method for producing dopaminergic neuron progenitor cell | Apr 23, 2017 | Issued |
Array
(
[id] => 11992432
[patent_doc_number] => 20170296587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'STEM CELL THERAPY OF NEUROLOGICAL MANIFESTATIONS OF A VIRAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/490778
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10580
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490778
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490778 | STEM CELL THERAPY OF NEUROLOGICAL MANIFESTATIONS OF A VIRAL INFECTION | Apr 17, 2017 | Abandoned |
Array
(
[id] => 15264921
[patent_doc_number] => 20190381194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => COMPOSITIONS FOR TREATMENT OF WET AGE-REALTED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/093420
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093420 | Compositions for treatment of wet age-related macular degeneration | Apr 13, 2017 | Issued |
Array
(
[id] => 18558761
[patent_doc_number] => 11723986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy
[patent_app_type] => utility
[patent_app_number] => 16/093022
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 73
[patent_no_of_words] => 15619
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093022 | Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy | Apr 13, 2017 | Issued |
Array
(
[id] => 18683946
[patent_doc_number] => 11779656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Gene therapy for treating hemophilia A
[patent_app_type] => utility
[patent_app_number] => 16/093798
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 30
[patent_no_of_words] => 19158
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093798 | Gene therapy for treating hemophilia A | Apr 12, 2017 | Issued |
Array
(
[id] => 14310243
[patent_doc_number] => 20190144825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies
[patent_app_type] => utility
[patent_app_number] => 16/092068
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092068 | Methods of treating cancer using cell based therapies | Apr 4, 2017 | Issued |
Array
(
[id] => 18666497
[patent_doc_number] => 11773375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytes
[patent_app_type] => utility
[patent_app_number] => 16/088227
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13160
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088227 | In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytes | Mar 26, 2017 | Issued |
Array
(
[id] => 11980848
[patent_doc_number] => 20170285002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHOD FOR RECONSTITUTING TUMOR WITH MICROENVIRONMENT'
[patent_app_type] => utility
[patent_app_number] => 15/461217
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 15249
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461217
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461217 | METHOD FOR RECONSTITUTING TUMOR WITH MICROENVIRONMENT | Mar 15, 2017 | Abandoned |
Array
(
[id] => 11727112
[patent_doc_number] => 20170188556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE'
[patent_app_type] => utility
[patent_app_number] => 15/459453
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17559
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459453
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459453 | Non-human animals having a humanized B-cell activating factor gene | Mar 14, 2017 | Issued |
Array
(
[id] => 16328681
[patent_doc_number] => 20200299647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/084060
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084060 | NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION | Mar 12, 2017 | Abandoned |
Array
(
[id] => 11961288
[patent_doc_number] => 20170265441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHOD FOR PRODUCING ANIMAL MODEL OF OSTEOBLASTIC BONE METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 15/445532
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9046
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15445532
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/445532 | METHOD FOR PRODUCING ANIMAL MODEL OF OSTEOBLASTIC BONE METASTASIS | Feb 27, 2017 | Abandoned |
Array
(
[id] => 14496041
[patent_doc_number] => 20190191675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => ATOPIC DERMATITIS MODEL NON-HUMAN ANIMAL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/079244
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079244 | Atopic dermatitis model non-human animal and use thereof | Feb 23, 2017 | Issued |